ARTELO BIOSCIENCES, INC. Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ARTELO BIOSCIENCES, INC. stock issued during period, shares, new issues for the quarter ending 2025-09-30 was 50.86K shares.
- ARTELO BIOSCIENCES, INC. stock issued during period, shares, new issues for the quarter ending 2024-03-31 was 372.01K shares.
- ARTELO BIOSCIENCES, INC. stock issued during period, shares, new issues for the quarter ending 2023-12-31 was 26.61K shares.
- ARTELO BIOSCIENCES, INC. stock issued during period, shares, new issues for fiscal 2023 was 333.27K shares.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2025-09-30 | 50.86K shares 10-Q · filed 2025-11-12 | |
| 2024-03-31 | 372.01K shares 10-Q · filed 2024-05-13 | |
| 2023-12-31 | 26.61K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | 333.27K shares 10-K · filed 2024-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |